
Purines and Pyrimidine Derivatives
Purines have a bicyclic structure, consisting of a six-membered ring fused to a five-membered ring, both containing nitrogen atoms in key positions. Purine derivatives, such as adenine and guanine, are essential for the formation of DNA and RNA. These compounds have therapeutic applications in cancer and viral disease treatments by inhibiting cell replication. Pyrimidines, on the other hand, have a monocyclic six-membered structure with two nitrogen atoms. Their derivatives, such as cytosine, thymine, and uracil, are also essential components of DNA and RNA and are used in chemotherapy and antiviral treatments.
At CymitQuimica, we offer purine and pyrimidine derivatives for research in molecular biology, genomics, and the development of innovative therapies.
Found 8901 products of "Purines and Pyrimidine Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Clopidogrel Acid N-Oxide (5-((S)-carboxy(2-chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H14ClNO3SColor and Shape:White Off-White SolidMolecular weight:323.03829Caffeine Related Compound F (1,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C7H8N4O2Color and Shape:White Fine PowderMolecular weight:180.06473Pemetrexed Disodium Enantiomer ((2R)-2-[[4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid, sodium salt)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C20H19N5O6NaColor and Shape:Pale Green SolidMolecular weight:576.5Clopidogrel Bisulfate
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H16ClNO2S·H2SO4Color and Shape:White Off-White PowderMolecular weight:321.05903Ondansetron Related Compound A (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride)
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C16H20N2O·HClColor and Shape:White SolidMolecular weight:256.15756Clopidogrel Related Compound C (methyl (-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen sulfate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H16ClNO2S·H2SO4Color and Shape:White PowderMolecular weight:321.05903Allopurinol Related Compound B (5-(formylamino)-1H-pyrazole-4-carboxamide)
CAS:Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C5H6N4O2Color and Shape:White PowderMolecular weight:154.04908Allopurinol Related Compound A (3-Amino-4-carboxamidopyrazole Hemisulfate)
CAS:Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C4H6N4OH2O4SColor and Shape:Off-White Yellow PowderMolecular weight:350.31Allopurinol Related Compound E (Ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate)
CAS:Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C7H9N3O3Color and Shape:White Off-White PowderMolecular weight:183.06439Febuxostat Related Compound E (2-(3-Cyano-4-propoxyphenyl)-4-methylthiazole-5-carboxylic acid)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C15H14N2O3SColor and Shape:White Fine PowderMolecular weight:302.07251Methyl 2-chloro-β-D-phenylalanine (methyl (R)-2-amino-2-(2-chlorophenyl)acetate, hydrochloride)
CAS:Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, nesoiFormula:C9H10ClNO2·HClColor and Shape:White Off-White SolidMolecular weight:235.01668Imidazole (1H-Imidazole)
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormula:C3H4N2Color and Shape:White Light Yellow Crystalline PowderMolecular weight:68.03745Clopidogrel Open Ring Methyl Ester Hydrochloride (methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H16ClNO2SHClColor and Shape:White Off-White SolidMolecular weight:346.28Febuxostat Related Compound D (2-[4-(sec-Butoxy)-3-cyanophenyl]-4-methylthiazole-5-carboxylic acid)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C16H16N2O3SColor and Shape:Off-White Fine PowderMolecular weight:316.08816Allopurinol Related Compound C (5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide)
CAS:Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C6H6N6OColor and Shape:White Off-White Crystalline PowderMolecular weight:178.06031Pemetrexed Acid N-Hydroxysuccinimide Ester (2,5-dioxopyrrolidin-1-yl 4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoate)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C19H17N5O5Color and Shape:White Off-White SolidMolecular weight:395.12297Theophylline
CAS:Theophylline and aminophylline (excluding fenetylline) and their derivatives, salts thereof, not elsewhere specified or includedFormula:C7H8N4O2Color and Shape:White PowderMolecular weight:180.17 g/molClopidogrel-β-D-glucuronide ((2S,3S,4S,5R,6S)-6-((S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C21H22ClNO8SColor and Shape:White Off-White SolidMolecular weight:483.07547Febuxostat Related Compound C (Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C14H12N2O3SColor and Shape:Off-White Fine PowderMolecular weight:288.05686Clopidogrel N-Oxide (5-((S)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H16ClNO3SColor and Shape:Pale Yellow SolidMolecular weight:337.05394

